EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, KLRS: Kalaris Therapeutics Inc

04 Nov 25 15:59
LAST:

4.790

CHANGE:
 0.28		OPEN:
4.820		HIGH:
4.990		ASK:
0.000		VOLUME:
36.9K
CHG(%):
5.61		PREV:
4.990		LOW:
4.670		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Nov 254.8204.9904.6704.71045.2K
03 Nov 255.0805.4504.7804.990108.6K
31 Oct 254.7605.1204.7105.03049.3K
30 Oct 254.8204.9204.7004.74025.2K
29 Oct 254.9805.2434.7104.87042.6K
28 Oct 254.9005.3004.7135.000145.7K
27 Oct 254.7604.9604.6024.86068.5K
24 Oct 254.8504.9804.7504.77042.2K
23 Oct 254.4105.0504.4004.890110.5K
22 Oct 254.7004.7004.2704.38097.0K

COMPANY PROFILE

Name:Kalaris Therapeutics Inc
About:Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.
Sector:Healthcare
Industry:Biotechnology
Address:628 Middlefield Road, Palo Alto, CA, United States, 94301
Website:https://kalaristx.com
FIGI:BBG00P80SH34

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-6.35 
Forward P/E:-2.30 
PEG Ratio:-0.03 
Price to Book:1.77 
Return on Assets:-4.41 
Return on Equity:0.33 
EPS Ratio:-2.71 
Shares:18.7M 
Market Cap:89.58M 

TECHNICAL INDICATORS

MA5:4.871.6%
MA10:4.820.7%
MA20:4.892.0%
MA50:4.902.2%
MA100:3.7328.5%
STO14:30.84
RSI14:46.10
WPR14:-49.23
MTM14:-0.08
ROC14:-0.02 
ATR:0.43 
Week High:5.4513.8%
Week Low:4.672.6%
Month High:8.8183.8%
Month Low:4.27
Volatility:18.86 

RECENT SPLITS

Date Ratio
16 Jan 20251-23